Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

INSTIL BIO, INC.

(A2QP62)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAnalystenempfehlungenAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über INSTIL BIO, INC.
20.09.INSTIL BIO, INC.(NASDAQGS : TIL) added to S&P Global BMI Index
16.09.INSTIL BIO : Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Mela..
16.09.INSTIL BIO, INC. : Other Events (form 8-K)
16.09.INSTIL BIO : Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Mela..
16.09.Instil Bio Presents Subset Analysis of Patients with Checkpoint-Refractory Advanced Mel..
15.09.109,812,253 Common Stock of Instil Bio, Inc. are subject to a Lock-Up Agreement Ending ..
15.09.Certain Options of Instil Bio, Inc. are subject to a Lock-Up Agreement Ending on 15-SEP..
13.09.ADDITIONAL COHORTS : ITIL-168 clinical trial expanded during IND review process with two a..
13.09.INSTIL BIO, INC. : Other Events (form 8-K)
13.09.INSTIL BIO : Receives Green Light from US FDA to Start Phase 2 Clinical Trial of its Melan..
13.09.INSTIL BIO : Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients with..
13.09.Instil Bio Receives IND Clearance to Initiate a Phase 2 Clinical Trial for Patients wit..
02.09.INSTIL BIO : to Present at Upcoming Investor Conferences in September
12.08.INSTIL BIO : Presented compassionate use study in advanced melanoma demonstrating 67% of s..
12.08.INSTIL BIO : Management's Discussion and Analysis of Financial Condition and Results of Op..
12.08.INSTIL BIO, INC. : Results of Operations and Financial Condition (form 8-K)
12.08.INSTIL BIO : Reports Second Quarter 2021 Financial Results and Provides Corporate Update
12.08.Instil Bio, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Mont..
21.06.INSTIL BIO, INC.(NASDAQGS : TIL) added to S&P TMI Index
01.06.Instil Bio to Present at the Jefferies Virtual Healthcare Conference
13.05.INSTIL BIO, INC. : Results of Operations and Financial Condition (form 8-K)
13.05.INSTIL BIO : Management's Discussion and Analysis of Financial Condition and Results of Op..
13.05.INSTIL BIO : Q1 Net Loss Widens; Expenses Grow
13.05.INSTIL BIO : Reports First Quarter 2021 Financial Results and Provides Corporate Update
13.05.Instil Bio, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March..
27.04.INSTIL BIO, INC. : Other Events (form 8-K)
27.04.Instil Bio, Inc Receives Orphan Drug Designation from the U.S. Food and Drug Administra..
27.04.INSTIL BIO : Receives FDA Orphan Drug Designation for ITIL-168 in Melanoma
27.04.INSTIL BIO : Receives Orphan Drug Designation for ITIL-168 in Melanoma
13.04.INSTIL BIO, INC. : Other Events (form 8-K)
12.04.Instil Bio Presents Clinical Data in Metastatic Melanoma in a Late-Breaking e-Poster at..
12.04.Instil Bio, Inc. Presents Clinical Data from Compassionate Use Program for the Treatmen..
22.03.INSTIL BIO, INC.(NASDAQGS : TIL) added to NASDAQ Composite Index
18.03.Instil Bio, Inc. has completed an IPO in the amount of $320 million.
26.02.Instil Bio, Inc. has filed an IPO in the amount of $100 million.
23.02.Instil Bio, Inc. announced that it has received $185.449878 million in funding from CPM..
12.01.Instil Bio, Inc. acquired Immetacyte Limited $19.5 million.
2020Instil Bio, Inc. announced that it expects to receive $185.449881 million in funding fr..
2020Instil Bio, Inc. announced that it expects to receive $185.499893 million in funding
2020Instil Bio, Inc. announced that it has received $25 million in funding
2020Instil Bio, Inc. announced that it has received $0.515917 million in funding
2020Instil Bio, Inc. announced that it has received $170.199973 million in funding from CPM..
2020Instil Bio, Inc. announced that it expects to receive $170.199973 million in funding fr..
2019Instil Bio, Inc. announced that it expects to receive $0.515917 million in funding
2019Instil Bio, Inc. announced that it expects to receive $15 million in funding